Canada-UK AI 2019 : AI-driven biomaterial screening to accelerate medical device development and translation

点击翻译按钮获取中文摘要

Our multi-disciplinary team will leverage the power of artificial intelligence, computer simulation and high-throughput screening approaches to create biomaterials for regenerative medicine in a sustainable, rapid and rational framework. Conventional engineering processes of biomaterials are expensive and laborious that has significantly impeded the translation from bench to bedside. To mitigate this unmet challenge, we will use combinatorial numerical simulations and machine learning models to generate and analyze large-scale and multi-modality synthetic data of cell-biomaterial interactions. Such application will effectively narrow down material choices and lead to hypothesis-driven empirical experiments for model verification. Novel high-throughput arrays containing 3D cell-laden hydrogels will be used to conduct thousands of cell-biomaterial experiments. We will further scale up the AI-informed material design and apply to vocal fold tissue engineering. Lastly, we will perform a cost analysis of this new AI-driven biomaterial design and screening with that of the conventional hypothesis-driven approach. We anticipate that the implementation of AI in biomaterial therapeutics will dramatically reduce the finance, time and labor while accelerate the development of personalized and precise biomaterials for medical applications.